Skip to content

Abivax

  • EN
  • FR
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
  • EN
  • FR

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

MyPharma Editions

July 2, 2020

Covid-19 : Abivax traite un 1er patient dans l’essai de Phase 2b/3 d’ABX464

Option Finance

July 2, 2020

ABIVAX traite un premier patient avec son médicament contre le Covid-19

Boursier.com

July 2, 2020

Abivax traite un premier patient dans l’essai de phase 2b/3 d’ABX464

PMLiVE

July 2, 2020

Abivax doses first patient in phase 2b/3 COVID-19 clinical trial

The Rheumatologist

June 29, 2020

ABX464 in Phase 2a Trials for RA

  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 46

References available upon request.

© 2025 All rights reserved by Abivax 07/2024 Privacy and Terms of Use
Consent Preferences
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn